Abivax S.A. ABVX
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 55th percentile, 5-year average -14.2x
Near the top of its 5-year range · 89th percentile, 5-year average -36.7x
#5131 of 5331 stocks by PB (1 = cheapest)
Above its usual level · 69th percentile, 5-year average 800.5x
#5101 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 18.93 | – | -36.66 | 89% (pricier than usual) | #5131 of 5331 (1 = cheapest) |
| PE | -14.86 | -22.85 | -14.22 | 55% (pricier than usual) | – |
| PS | 1,560.11 | 183.34 | 800.52 | 69% (pricier than usual) | #5101 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ABVX.
Sign in to join the discussion.